3.0.0 7248 2025-05-27T14:12:59Z 2025-05-27T14:12:59Z House H HR 2024-02-06 118 <pre>[Congressional Record Volume 170, Number 21 (Tuesday, February 6, 2024)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. CARTER of Georgia:H.R. 7248.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the ConstitutionThe single subject of this legislation is:To amend the Federal Food, Drug, and Cosmetic Act toestablish a process for the qualification of nonclinicaltesting methods to reduce and replace the use of animals innonclinical research, improve the predictivity of nonclinicaltesting methods, and reduce development time for a biologicalproduct or other drug, and for other purposes.[Page H503]</pre> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2024-02-09T21:49:27Z Referred To 2024-02-06T17:00:45Z 118 5046 S 2024-12-16 Held at the desk. 14:40:35 Related bill CRS 2024-02-09 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2024-02-06 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2024-02-06 Introduced in House IntroReferral Intro-H 9 Library of Congress 2024-02-06 Introduced in House IntroReferral 1000 9 Library of Congress C001103 Rep. Carter, Earl L. "Buddy" [R-GA-1] Earl Carter R GA L. "Buddy" 1 N B001300 Rep. Barragan, Nanette Diaz [D-CA-44] Nanette Barragan D CA Diaz 44 2024-02-06 True H001086 Rep. Harshbarger, Diana [R-TN-1] Diana Harshbarger R TN 1 2024-02-06 True B001260 Rep. Buchanan, Vern [R-FL-16] Vern Buchanan R FL 16 2024-02-06 True C001125 Rep. Carter, Troy [D-LA-2] Troy Carter D LA 2 2024-02-06 True W000823 Rep. Waltz, Michael [R-FL-6] Michael Waltz R FL 6 2024-02-06 True D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2024-02-06 True N000026 Rep. Nehls, Troy E. [R-TX-22] Troy Nehls R TX E. 22 2024-02-06 True G000589 Rep. Gooden, Lance [R-TX-5] Lance Gooden R TX 5 2024-02-06 True C001120 Rep. Crenshaw, Dan [R-TX-2] Dan Crenshaw R TX 2 2024-02-06 True F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2024-02-06 True V000129 Rep. Valadao, David G. [R-CA-22] David Valadao R CA G. 22 2024-02-13 False N000191 Rep. Neguse, Joe [D-CO-2] Joe Neguse D CO 2 2024-02-14 False B001257 Rep. Bilirakis, Gus M. [R-FL-12] Gus Bilirakis R FL M. 12 2024-02-23 False D000230 Rep. Davis, Donald G. [D-NC-1] Donald Davis D NC G. 1 2024-02-23 False G000583 Rep. Gottheimer, Josh [D-NJ-5] Josh Gottheimer D NJ 5 2024-02-29 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] Eleanor Norton D DC Holmes 0 2024-03-05 False G000599 Rep. Goldman, Daniel S. [D-NY-10] Daniel Goldman D NY S. 10 2024-03-05 False R000305 Rep. Ross, Deborah K. [D-NC-2] Deborah Ross D NC K. 2 2024-03-11 False P000620 Rep. Pettersen, Brittany [D-CO-7] Brittany Pettersen D CO 7 2024-03-19 False L000397 Rep. Lofgren, Zoe [D-CA-18] Zoe Lofgren D CA 18 2024-03-21 False T000468 Rep. Titus, Dina [D-NV-1] Dina Titus D NV 1 2024-03-22 False L000599 Rep. Lawler, Michael [R-NY-17] Michael Lawler R NY 17 2024-03-29 False O000019 Rep. Obernolte, Jay [R-CA-23] Jay Obernolte R CA 23 2024-04-05 False T000481 Rep. Tlaib, Rashida [D-MI-12] Rashida Tlaib D MI 12 2024-04-17 False B001309 Rep. Burchett, Tim [R-TN-2] Tim Burchett R TN 2 2024-04-19 False S000522 Rep. Smith, Christopher H. [R-NJ-4] Christopher Smith R NJ H. 4 2024-04-19 False M000194 Rep. Mace, Nancy [R-SC-1] Nancy Mace R SC 1 2024-04-23 False F000471 Rep. Fitzgerald, Scott [R-WI-5] Scott Fitzgerald R WI 5 2024-05-01 False B001298 Rep. Bacon, Don [R-NE-2] Don Bacon R NE 2 2024-05-10 False M001225 Rep. Mullin, Kevin [D-CA-15] Kevin Mullin D CA 15 2024-05-14 False C001097 Rep. Cárdenas, Tony [D-CA-29] Tony Cárdenas D CA 29 2024-05-21 False C001126 Rep. Carey, Mike [R-OH-15] Mike Carey R OH 15 2024-06-03 False G000586 Rep. García, Jesús G. "Chuy" [D-IL-4] Jesús García D IL G. "Chuy" 4 2024-06-05 False F000462 Rep. Frankel, Lois [D-FL-22] Lois Frankel D FL 22 2024-07-22 False C001080 Rep. Chu, Judy [D-CA-28] Judy Chu D CA 28 2024-07-22 False S001221 Rep. Scholten, Hillary J. [D-MI-3] Hillary Scholten D MI J. 3 2024-08-16 False C001121 Rep. Crow, Jason [D-CO-6] Jason Crow D CO 6 2024-08-23 False D000632 Rep. D'Esposito, Anthony [R-NY-4] Anthony D'Esposito R NY 4 2024-08-23 False G000597 Rep. Garbarino, Andrew R. [R-NY-2] Andrew Garbarino R NY R. 2 2024-09-03 False H001090 Rep. Harder, Josh [D-CA-9] Josh Harder D CA 9 2024-09-10 False N000002 Rep. Nadler, Jerrold [D-NY-12] Jerrold Nadler D NY 12 2024-10-25 False L000590 Rep. Lee, Susie [D-NV-3] Susie Lee D NV 3 2024-11-20 False T000478 Rep. Tenney, Claudia [R-NY-24] Claudia Tenney R NY 24 2024-12-05 False C000059 Rep. Calvert, Ken [R-CA-41] Ken Calvert R CA 41 2024-12-09 False D000399 Rep. Doggett, Lloyd [D-TX-37] Lloyd Doggett D TX 37 2024-12-16 False M000317 Rep. Malliotakis, Nicole [R-NY-11] Nicole Malliotakis R NY 11 2024-12-17 False Health Administrative law and regulatory procedures 2024-04-03T20:14:48Z Animal protection and human-animal relationships 2024-04-03T20:14:43Z Congressional oversight 2024-04-03T20:17:03Z Department of Health and Human Services 2024-04-03T20:17:11Z Drug safety, medical device, and laboratory regulation 2024-04-03T20:14:33Z Food and Drug Administration (FDA) 2024-04-03T20:14:24Z Government information and archives 2024-04-03T20:14:55Z Internet, web applications, social media 2024-04-03T20:15:06Z Prescription drugs 2024-04-03T20:14:38Z Health 2024-02-28T17:30:54Z

00 2024-02-06 Introduced in House 2024-04-01T16:15:31Z <p><b>FDA Modernization Act 3.0</b></p> <p>This bill requires the Food and Drug Administration (FDA) to establish a process that supports nonclinical testing methods for drug development that do not involve the use of animals.</p> <p>Specifically, the FDA must establish a pathway by which entities may apply to have nonclinical testing methods approved for use in a particular context. Qualifying methods must be intended to replace or reduce animal testing and to either improve the safety and efficacy of nonclinical testing or reduce the time to develop a drug. The FDA must issue its decision within 180 days of receiving an application. The FDA must also prioritize the review of applications for drugs that are developed using an approved nonclinical testing method. </p> <p>The FDA must annually post a report on its website that summarizes the results of the bill's implementation, including the number of applications received, types of methods that were approved, and the estimated number of animals saved as result of these methods.</p>

Display Title 45 2024-06-07T21:12:16Z Short Title(s) as Introduced 101 2024-05-24T13:34:09Z Introduced in House IH Official Title as Introduced 6 2024-03-18T22:14:46Z Introduced in House IH Introduced in House 2024-02-06T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr7248ih/xml/BILLS-118hr7248ih.xml 2024-02-09 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.